Israel Englander Invitae Corp Call Options Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$1.05 - $1.63 $105,000 - $163,000	-100,000 Reduced 16.67%	500,000 $565,000
Q1 2023 May 15, 2023	BUY	$1.2 - $2.73 $120,000 - $273,000	100,000 Added 20.0%	600,000 $810,000
Q4 2022 Feb 14, 2023	SELL	$1.71 - $3.61 $119,700 - $252,700	-70,000 Reduced 12.28%	500,000 $930,000
Q3 2022 Nov 14, 2022	BUY	$1.9 - $8.63 $1.08 Million - $4.92 Million	570,000 New	570,000 $1.4 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.